Tectonic Therapeutic To Participate In Upcoming Investor Conferences
| Date: | November 11, 2026 |
| Time: | 4:00 PM ET |
| Location: | New York, NY |
| Format: | Fireside Chat |
| Presenter: | Alise Reicin, MD, President and Chief Executive Officer |
| Webcast: | Link |
Piper Sandler 38 th Annual Healthcare Conference
| Date: | December 2, 2026 |
| Time: | 10:00 AM ET |
| Location: | New York, NY |
| Format: | Fireside Chat |
| Presenter: | Alise Reicin, MD, President and Chief Executive Officer |
| Webcast: | Link |
The live fireside chats can also be accessed under“Events & Presentations” on the Investors section of the Tectonic website at . Once the live events have concluded, a replay of both events will be available on the Company's website for approximately 90 days.
The Tectonic management team will host one-on-one meetings during both conferences. Interested investors should contact their Stifel and Piper representatives to schedule meetings.
About Tectonic
Tectonic Therapeutic is a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Leveraging its proprietary technology platform called GEODeTM (GPCRs Engineered for Optimal Discovery), Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. Tectonic focuses on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent, as these are areas where new medicines have the potential to improve patient quality of life. Tectonic is headquartered in Watertown, Massachusetts. For more information, please visit and follow us on LinkedIn.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment